Glial Cells

Glial Cells

Introduction

```mermaid
flowchart TD
classDef gene fill:#0a1f0a,stroke:#4caf50
classDef protein fill:#0a1929,stroke:#2196f3
classDef disease fill:#2d0f0f,stroke:#e91e63
classDef pathway fill:#3e2200,stroke:#ff9800
classDef mechanism fill:#1a0a1f,stroke:#9c27b0
classDef therapeutic fill:#e0f2f1,stroke:#009688
Glial_Cells["Glial Cells"] -->|"involved_in"| Parkinson_s_Disease["Parkinson's Disease"]
Glial_Cells["Glial Cells"] -->|"causes"| Neuronal_Damage["Neuronal Damage"]
Glial_Cells["Glial Cells"] -->|"involved_in"| Neuroinflammation["Neuroinflammation"]
Glial_Cells["Glial Cells"] ==>|"upregulates"| Proinflammatory_Cytokines["Proinflammatory Cytokines"]
Glial_Cells["Glial Cells"] -->|"contributes_to"| Alzheimer_s_Disease["Alzheimer's Disease"]
Glial_Cells["Glial Cells"] -->|"involved_in"| Alzheimer_s_Disease["Alzheimer's Disease"]
Glial_Cells["Glial Cells"] -->|"mediates"| Gender_Differences_in_Neurodegeneration["Gender Differences in Neurodegeneration"]
Glial_Cells["Glial Cells"] -->|"involved_in"| Synapse_Pathology["Synapse Pathology"]
Glial_Cells["Glial Cells"] -->|"component_of"| Neurovascular_Unit["Neurovascular Unit"]
Glial_Cells["Glial Cells"] -->|"mediates"| Neuroinflammation["Neuroinflammation"]
Glial_Cells["Glial Cells"] -->|"contributes_to"| Parkinson_S_Disease["Parkinson'S Disease"]
Glial_Cells["Glial Cells"] -->|"modulates"| Neurodegeneration["Neurodegeneration"]
Glial_Cells["Glial Cells"] -->|"associated_with"| Neurodegeneration["Neurodegeneration"]
Glial_Cells["Gl

Glial Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Glial Cells</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Glial Cells</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>

Glial cells (neuroglia) are non-neuronal cells that constitute approximately 50% of the human brain volume. Once considered mere support cells, astrocytes, oligodendrocytes, and microglia are now recognized as active participants in neural circuit function, synaptic transmission, and brain homeostasis [@allen2009].

Types of Glial Cells

Astrocytes

Characteristics:

• Star-shaped cells with multiple branching processes
• Express GFAP (glial fibrillary acidic protein)
• Contact both blood vessels and neurons
• Form the blood-brain barrier alongside endothelial cells

• Synaptic support: Provide metabolic support to neurons, recycle neurotransmitters
• Ion homeostasis: Regulate extracellular potassium and calcium
• Water balance: Aquaporin-4 channels for water transport
• Neuroinflammation: Release cytokines and chemokines in response to injury

Oligodendrocytes (CNS) and Schwann Cells (PNS)

CNS Oligodendrocytes:

• Each oligodendrocyte myelinates multiple axons (up to 50)
• Express MBP (myelin basic protein) and PLP (proteolipid protein)
• Form internodes with nodes of Ranvier for saltatory conduction

• Myelinate single axons
• Express P0 and PMP22 proteins
• Support peripheral nerve regeneration

Microglia

Characteristics:

• Small cell bodies with ramified processes
• Express IBA1 (ionized calcium-binding adapter molecule 1)
• Constantly survey the brain parenchyma
• Turn over slowly throughout life

• Immune surveillance: Phagocytose debris and pathogens
• Synaptic pruning: Eliminate excess synapses during development
• Neuroinflammation: Release pro-inflammatory cytokines when activated
• Support neuronal health: Produce neurotrophic factors

Glial Cells in Neurodegenerative Diseases

Alzheimer's Disease

Astrocytes:

• Reactive astrocytes surround amyloid plaques
• Lose normal functions ( glutamate recycling)
• Contribute to neuroinflammation
• Form astrocytic plaques (Aβ accumulation)

• Chronic activation around plaques
• Create neurotoxic inflammatory environment
• TREM2 variants increase AD risk
• Failed clearance of Aβ and tau

• Myelin degeneration precedes clinical symptoms
• Vulnerable to oxidative stress
• Loss contributes to white matter atrophy

Parkinson's Disease

Astrocytes:

• Reactive astrocytes in substantia nigra
• Impaired dopamine metabolism
• May spread α-synuclein pathology

• Chronic activation in substantia nigra
• NADPH oxidase-mediated oxidative stress
• Contribute to dopaminergic neuron death

• Myelin abnormalities in PD brains
• α-Synuclein accumulation in oligodendrocytes
• Vulnerable to iron-induced oxidative stress

Amyotrophic Lateral Sclerosis (ALS)

Astrocytes:

• Loss of glutamate transporters (EAAT2)
• Excitotoxicity due to glutamate accumulation
• Non-cell autonomous toxicity to motor neurons

• Activated in spinal cord and motor cortex
• Pro-inflammatory cytokine release (TNF-α, IL-1β)
• Mutant SOD1 in microglia contributes to disease

• Pre-motor neuron degeneration
• Failed remyelination in progressive stages
• Oligodendrocyte precursor cells fail to differentiate

Glial-Neuronal Interactions

Tripartite Synapse

• Pre-synaptic neuron
• Post-synaptic neuron
• Perisynaptic astrocyte

Neurovascular Coupling

Gliotransmission

• Glutamate (via vesicles)
• D-serine (co-agonist for NMDA receptors)
• ATP/adenosine (modulates synaptic plasticity)

Therapeutic Targets

Astrocyte-Targeted Therapies

• EAAT2 modulators: Enhance glutamate uptake
• A1 adenosine receptor antagonists: Block astrocyte-mediated toxicity
• GFAP inhibitors: Reduce reactive astrogliosis

Microglia-Targeted Therapies

• TREM2 agonists: Enhance phagocytosis
• CD33 inhibitors: Reduce amyloid clearance blockade
• Anti-inflammatory drugs: Modulate neuroinflammation

Oligodendrocyte-Targeted Therapies

• Remyelination promoters: LINGO-1 antagonists
• MBP stabilizers: Protect existing myelin
• OPC recruitment: Enhance oligodendrocyte precursor differentiation

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)